Nippon Shinyaku Co., Ltd. (TYO: 4516)

Market Cap	233.44B
Revenue (ttm)	150.37B
Net Income (ttm)	27.37B
Shares Out	67.35M
EPS (ttm)	406.31
PE Ratio	8.53
Forward PE	8.56
Dividend	124.00 (3.54%)
Ex-Dividend Date	Sep 27, 2024

Volume	219,800
Open	3,577.00
Previous Close	n/a
Day's Range	n/a
52-Week Range	2,694.00 - 6,784.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2024

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company’s Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headq...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1911
• Employees: 2,213
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4516

Financial Performance

In 2023, Nippon Shinyaku's revenue was 148.26 billion, an increase of 2.83% compared to the previous year's 144.18 billion. Earnings were 25.85 billion, an increase of 13.32%.